| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/24/1997 | WO1997026336A1 Compositions for treating anemia |
| 07/24/1997 | WO1997026335A1 Db, the receptor for leptin, nucleic acids encoding the receptor, and uses thereof |
| 07/24/1997 | WO1997026334A1 Recombinant expression of proteins from secretory cell lines |
| 07/24/1997 | WO1997026331A2 Use of neuronal apoptosis inhibitor protein (naip) |
| 07/24/1997 | WO1997026329A1 Monoclonal antibody to herpes simplex virus and cell line producing same |
| 07/24/1997 | WO1997026327A1 Compositions and methods for mediating cell cycle progression |
| 07/24/1997 | WO1997026326A1 Isolation of precursor cells from hematopoietic and non-hematopoietic tissues and their use |
| 07/24/1997 | WO1997026325A1 Compositions and their uses for transfer of down-regulatory genes into cells associated with inflammatory responses |
| 07/24/1997 | WO1997026321A2 Recombinant expression of proteins from secretory cell lines |
| 07/24/1997 | WO1997026320A2 Product for inhibition of attachment of h. influenzae to human cells |
| 07/24/1997 | WO1997026279A1 Synthetic il-10 analogues |
| 07/24/1997 | WO1997026278A1 Synthetic il-10 analogues |
| 07/24/1997 | WO1997026276A2 Vertebrate fringe proteins |
| 07/24/1997 | WO1997026274A1 Leptospiral outer membrane proteins |
| 07/24/1997 | WO1997026273A1 Borrelia burgdorferi outer membrane proteins |
| 07/24/1997 | WO1997026272A1 Leptin receptor variants |
| 07/24/1997 | WO1997026271A1 Novel tumor suppressor gene, dpc4 |
| 07/24/1997 | WO1997026268A2 A process for inhibiting smooth muscle cell proliferation and motility |
| 07/24/1997 | WO1997026014A1 Novel medical use of an ace-inhibitor for treatment of dyspeptic symptoms |
| 07/24/1997 | WO1997026013A1 Obesity protein formulations |
| 07/24/1997 | WO1997026012A1 Obesity protein formulations |
| 07/24/1997 | WO1997026011A1 Obesity protein formulations |
| 07/24/1997 | WO1997026010A1 Anticoagulant agents useful in treatment of thrombosis |
| 07/24/1997 | WO1997026009A1 Compounds capable of inhibiting hiv-1 infection |
| 07/24/1997 | WO1997026008A1 STREPTOCOCCAL C5a PEPTIDASE VACCINE |
| 07/24/1997 | WO1997026005A1 Igf-i in combination with hypoglycemics for treatment of diabetes |
| 07/24/1997 | WO1997026004A1 Obesity protein formulations |
| 07/24/1997 | WO1997026003A1 Cyclosporin formulation |
| 07/24/1997 | WO1997026000A1 Therapeutic applications of t-bam (cd40-l) technology to treat inflammatory kidney diseases______________________________________ |
| 07/24/1997 | WO1997025999A1 Peptides for altering osteoblast adhesion |
| 07/24/1997 | WO1997025994A1 Control of healing process |
| 07/24/1997 | WO1997025977A1 Pharmaceutical compositions |
| 07/24/1997 | WO1997025961A1 Bowman-birk inhibitor for male sexual dysfunction |
| 07/24/1997 | WO1997025959A2 Compositions and methods for the prevention and treatment of atherosclerosis and reperfusion injury with magnesium salts |
| 07/24/1997 | WO1997025926A1 Methods of detecting and treating vaso-occlusive crisis in sickle cell disease |
| 07/24/1997 | WO1997025862A1 Hepatitis pretreatment composition and method |
| 07/24/1997 | WO1997025860A1 Cellular immunogens useful as cancer vaccines |
| 07/24/1997 | WO1997018308A3 K-atp channel protein and methods relating to it |
| 07/24/1997 | WO1997018207A3 Novel macrocyclic compounds as metalloprotease inhibitors |
| 07/24/1997 | WO1997015668A3 Methods and compositions comprising glut-2 and glut-2 chimeras |
| 07/24/1997 | WO1997014808A3 Herpesvirus vectors and their uses |
| 07/24/1997 | WO1997010258A3 Antibodies against epitopes, exposed on surfaces of cancer cells outside desmosomes, of desmosomal cadherines |
| 07/24/1997 | WO1997007198A3 Dna sequences and secreted proteins encoded thereby |
| 07/24/1997 | WO1997006176A3 Peptide and o-glycan inhibitors of selectin mediated inflammation |
| 07/24/1997 | DE19602208A1 In-situ gebildete Arzneiform zur Abgabe von Enzymen an Wunden In-situ formed dosage form for delivering enzymes to wounds |
| 07/24/1997 | CA2844461A1 Compositions for treating anemia |
| 07/24/1997 | CA2678707A1 Pharmaceutical compositions comprising ascomycin derivatives |
| 07/24/1997 | CA2246431A1 Recombinant expression of proteins from secretory cell lines |
| 07/24/1997 | CA2246268A1 Recombinant expression of proteins from secretory cell lines |
| 07/24/1997 | CA2243531A1 Therapeutic applications of t-bam (cd40-l) technology to treat inflammatory kidney diseases______________________________________ |
| 07/24/1997 | CA2243518A1 Obesity protein formulations |
| 07/24/1997 | CA2243512A1 Obesity protein formulations |
| 07/24/1997 | CA2243505A1 Obesity protein formulations |
| 07/24/1997 | CA2243470A1 Recombinant aav virion for expressing epo in a mammal |
| 07/24/1997 | CA2243446A1 Db, the receptor for leptin, nucleic acids encoding the receptor, and uses thereof |
| 07/24/1997 | CA2243325A1 Bowman-birk inhibitor for male sexual dysfunction |
| 07/24/1997 | CA2243301A1 Novel tumor suppressor gene, dpc4 |
| 07/24/1997 | CA2243275A1 Synthetic il-10 analogues |
| 07/24/1997 | CA2243229A1 Obesity protein formulations |
| 07/24/1997 | CA2243081A1 Vertebrate fringe proteins |
| 07/24/1997 | CA2242911A1 Peptides for altering osteoblast adhesion |
| 07/24/1997 | CA2242376A1 Isolated tyrosinase derived peptides and uses thereof |
| 07/24/1997 | CA2241983A1 Control of healing process |
| 07/24/1997 | CA2241952A1 Cellular immunogens useful as cancer vaccines |
| 07/24/1997 | CA2240199A1 Novel medical use of an ace-inhibitor for treatment of dyspeptic symptoms |
| 07/24/1997 | CA2234680A1 Product for inhibition of attachment of h. influenzae to human cells |
| 07/24/1997 | CA2215900A1 Leptospiral outer membrane proteins |
| 07/23/1997 | EP0785272A1 Prolyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785271A1 Threonyl-tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785270A1 Staphylococcus aureus Seryl-tRNA synthetase |
| 07/23/1997 | EP0785269A1 Histidyl-tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785268A1 Staphylococcus aureus methionyl-tRNA synthetase |
| 07/23/1997 | EP0785267A1 Valyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785266A1 Arginyl-tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785265A1 Aspartyl tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785264A1 Lencyl t-RNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785263A1 Tryptophanyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785262A1 Phenylalanyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785261A1 Glutamyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785260A1 Alanyl-tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785259A1 Asparaginyl t-RNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785258A1 Staphylococcus aureus tyrosyl-tRNA synthetase |
| 07/23/1997 | EP0785257A1 Cysteinyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785256A1 Staphylococcus aureus glycyl-tRNA synthetase |
| 07/23/1997 | EP0785254A2 Phosphatidyl-ionsitol glycan class F (PIG-F), the cDNA encoding it and their use as medicament |
| 07/23/1997 | EP0785253A1 Dictyocaulus viviparus antigen for diagnosis of lungworm affection and for vaccination |
| 07/23/1997 | EP0785252A1 Antisense oligonucleotides against the alpha regulatory subunit of the cAMP dependent-protein kinase for treatment of cancer |
| 07/23/1997 | EP0785215A1 Gonadotropins with non-native disulfide bridges |
| 07/23/1997 | EP0785214A2 Amylase inhibitors |
| 07/23/1997 | EP0784983A2 Use of extracellular hemoglobin |
| 07/23/1997 | EP0784982A2 Obesity protein formulations |
| 07/23/1997 | EP0784981A2 Obesity protein formulations |
| 07/23/1997 | EP0784980A1 Collagen hydrolysis accelerator |
| 07/23/1997 | EP0784979A2 Obesity protein formulations |
| 07/23/1997 | EP0784978A2 Agents for inhibiting accumulation of visceral fat |
| 07/23/1997 | EP0784976A1 Immunosuppressive-activity potentiating compositions containing ascorbyl tocopheryl phosphoric acid diesters |
| 07/23/1997 | EP0784753A1 Axial flow valve system for linear compressor |
| 07/23/1997 | EP0784690A1 Complementary adenoviral vector systems and cell lines |
| 07/23/1997 | EP0784689A1 Microorganisms as therapeutic delivery systems |
| 07/23/1997 | EP0784686A1 Herpes simplex virus glycoprotein d variants |